Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL
Next-generation sequencing (NGS) of the rearranged immunoglobulin heavy-chain gene has emerged as a highly sensitive method to detect minimal residual disease (MRD) in B acute lymphoblastic leukemia/lymphoma (...
Source: Journal of Hematology and Oncology - Category: Hematology Authors: Shuhua Cheng, Giorgio Inghirami, Shuo Cheng and Wayne Tam Tags: Research Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Cancer & Oncology | Genetics | Hematology | Leukemia | Lymphoma